Author pages are created from data sourced from our academic publisher partnerships and public sources.
Preoperative saline versus gelatin for hip fracture patients; a randomized trial of 396 patients.
BACKGROUND The aim of this study was to determine if the preoperative administration of 500 ml of a gelatin colloid solution intravenously before hip fracture surgery improves outcome, compared with… Expand
Is Perioperative Blood Transfusion a Risk Factor for Mortality or Infection After Hip Fracture?
- P. Johnston, H. Wynn-Jones, D. Chakravarty, A. Boyle, M. Parker
- Journal of orthopaedic trauma
- 1 November 2006
Objectives: To assess whether allogeneic blood transfusion in the perioperative period is associated with changes in mortality or complication rates in patients undergoing surgical treatment for hip… Expand
Comparative pharmacokinetics of single and multiple-dose infliximab in Crohns disease patients
Securing intercostal drains.
- A. Boyle
- Journal of accident & emergency medicine
- 1 May 1999
As regards searching we already compare search strategies between two people, at least one of whom is an experienced MEDLINE searcher. Ifwe had an interested librarian then we would probably use one.… Expand
Adverse events and clinical outcome associated with drotrecogin alfa-activated: a single-center experience of 498 patients over 8 years.
- A. Boyle, C. McKenzie, S. Yassin, A. Mcluckie, D. Wyncoll
- Journal of critical care
- 1 June 2012
PURPOSE Licensed in 2002 for severe sepsis, drotrecogin alfa-activated (DAA) remains a much debated therapy particularly with respect to outcomes and a potentially increased risk of serious bleeding… Expand
Curating the space–time continuum
- Alison Boyle
- 1 April 2010
There cannot be too many jobs in physics that combine shaking hands with the Queen and rummaging around in filthy sheds, but I have one of them. As curator of astronomy and modern physics at London's… Expand
Outcomes and incidence of bleeding events associated with drotrecogin alfa: a single-centre experience of 440 patients
Although drotrecogin alfa activated (DAA) was approved in 2002 for the treatment of severe sepsis, controversy has surrounded this therapy especially with respect to the increased risk of serious… Expand